Ed Ebbers - 01 Jun 2021 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Reporting relationship: EVP & GM, Dermatology
Issuer ticker: PLSE
Reported as of: 01 Jun 2021
Net transaction value: -$27,859
SEC form: 4
Accepted by SEC: 03 Jun 2021, 17:37:09 UTC
Source filing: View source filing
Reporting owner signature: /s/ Sandra Gardiner, as Attorney-in-Fact

Key filing fact

Ed Ebbers filed Form 4 for Pulse Biosciences, Inc. (PLSE) on 03 Jun 2021.

Key facts

This page summarizes Ed Ebbers's Form 4 filing for Pulse Biosciences, Inc. (PLSE).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Jun 2021, 17:37.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: -$27,859.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PLSE transaction

Common Stock

Tax liability

Transaction value: $27,859
Shares: -1,485
Change %: -3.6%
Price: $18.76
Shares after: 39,300
Date: 01 Jun 2021
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the total number of shares withheld by the Company to settle the Reporting Person's minimum tax liability pursuant to the contractual provisions of the June 2018 Restricted Stock Unit grant agreement previously disclosed.

Footnote F2

Includes shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan.